A Phase I, Autologous ex Vivo Expanded and Activated NK Cell, Magicell-NK, Infusion for Colon Cancer Post Resection Study

NCT05394714 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Colon Cancer Stage I

Interventions

BIOLOGICAL: Magicell-NK contains NK cells suspended in 100 mL normal saline

Sponsor

Medigen Biotechnology Corporation